 Laura Fenton
Concepts (347)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 21 | 2024 | 3397 | 0.830 |
Why?
| | Brain Stem Neoplasms | 5 | 2015 | 81 | 0.810 |
Why?
| | Tomography, X-Ray Computed | 11 | 2014 | 2511 | 0.740 |
Why?
| | Scrotum | 2 | 2016 | 26 | 0.700 |
Why?
| | Neuroimaging | 1 | 2022 | 279 | 0.660 |
Why?
| | Brain | 6 | 2022 | 2677 | 0.590 |
Why?
| | Ganglioglioma | 2 | 2015 | 27 | 0.560 |
Why?
| | Wounds, Nonpenetrating | 3 | 2016 | 273 | 0.540 |
Why?
| | Esophagus | 3 | 2015 | 251 | 0.540 |
Why?
| | Diagnostic Techniques, Digestive System | 1 | 2015 | 12 | 0.500 |
Why?
| | Brain Diseases | 2 | 2019 | 134 | 0.480 |
Why?
| | Eosinophilic Esophagitis | 2 | 2020 | 318 | 0.480 |
Why?
| | Esophageal Stenosis | 1 | 2015 | 51 | 0.470 |
Why?
| | Infratentorial Neoplasms | 1 | 2014 | 55 | 0.420 |
Why?
| | Osteitis | 1 | 2013 | 2 | 0.420 |
Why?
| | Child | 34 | 2024 | 20962 | 0.410 |
Why?
| | Ultrasonography | 3 | 2016 | 713 | 0.410 |
Why?
| | Eosinophils | 1 | 2015 | 324 | 0.410 |
Why?
| | Positron-Emission Tomography | 2 | 2019 | 282 | 0.400 |
Why?
| | Glioma | 2 | 2009 | 351 | 0.390 |
Why?
| | Child, Preschool | 24 | 2019 | 10522 | 0.390 |
Why?
| | Prosthesis-Related Infections | 1 | 2013 | 75 | 0.380 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2014 | 210 | 0.380 |
Why?
| | Gastritis | 1 | 2013 | 96 | 0.370 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 23 | 0.370 |
Why?
| | Enteritis | 1 | 2013 | 93 | 0.370 |
Why?
| | Liver Neoplasms | 3 | 2008 | 636 | 0.360 |
Why?
| | Radiography | 8 | 2016 | 800 | 0.350 |
Why?
| | Infant | 21 | 2019 | 9018 | 0.340 |
Why?
| | Eosinophilia | 1 | 2013 | 204 | 0.340 |
Why?
| | Colitis | 1 | 2013 | 245 | 0.340 |
Why?
| | Radiation Injuries | 2 | 2019 | 135 | 0.330 |
Why?
| | Spinal Fusion | 1 | 2013 | 233 | 0.330 |
Why?
| | Diagnosis, Differential | 9 | 2024 | 1434 | 0.330 |
Why?
| | Nervous System Diseases | 1 | 2011 | 252 | 0.300 |
Why?
| | Adolescent | 25 | 2024 | 20451 | 0.280 |
Why?
| | Male | 41 | 2019 | 63759 | 0.280 |
Why?
| | Pamphlets | 1 | 2007 | 23 | 0.280 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1847 | 0.270 |
Why?
| | Astrocytoma | 2 | 2007 | 115 | 0.270 |
Why?
| | Mutation | 3 | 2014 | 3706 | 0.260 |
Why?
| | Humans | 59 | 2024 | 129847 | 0.260 |
Why?
| | Deglutition Disorders | 2 | 2020 | 133 | 0.260 |
Why?
| | Female | 44 | 2019 | 68829 | 0.250 |
Why?
| | Radiation Dosage | 1 | 2007 | 154 | 0.250 |
Why?
| | Infant, Newborn | 16 | 2019 | 5772 | 0.250 |
Why?
| | Stroke | 3 | 2022 | 1072 | 0.250 |
Why?
| | Reproducibility of Results | 6 | 2015 | 3089 | 0.250 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2008 | 270 | 0.240 |
Why?
| | Brain Neoplasms | 3 | 2012 | 1149 | 0.240 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 24 | 0.230 |
Why?
| | Retrospective Studies | 14 | 2024 | 14553 | 0.220 |
Why?
| | Ascorbic Acid Deficiency | 1 | 2024 | 7 | 0.220 |
Why?
| | Scurvy | 1 | 2024 | 14 | 0.220 |
Why?
| | Venous Thrombosis | 2 | 2016 | 176 | 0.210 |
Why?
| | Tomography, Emission-Computed | 1 | 2003 | 66 | 0.210 |
Why?
| | Encephalocele | 1 | 2022 | 7 | 0.200 |
Why?
| | Cerebral Cortex | 2 | 2019 | 439 | 0.200 |
Why?
| | Testicular Hydrocele | 1 | 2002 | 4 | 0.200 |
Why?
| | Neuroblastoma | 2 | 2010 | 151 | 0.200 |
Why?
| | Brain Stem | 1 | 2003 | 100 | 0.200 |
Why?
| | Teratoma | 1 | 2003 | 103 | 0.190 |
Why?
| | Diagnostic Errors | 1 | 2003 | 162 | 0.190 |
Why?
| | Rhabdoid Tumor | 1 | 2003 | 95 | 0.190 |
Why?
| | Neurofibroma, Plexiform | 1 | 2001 | 9 | 0.190 |
Why?
| | Abdomen | 1 | 2002 | 119 | 0.190 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2001 | 25 | 0.180 |
Why?
| | Mesentery | 1 | 2001 | 47 | 0.180 |
Why?
| | Child Abuse | 2 | 2012 | 513 | 0.180 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 95 | 0.180 |
Why?
| | Parietal Bone | 1 | 2000 | 8 | 0.180 |
Why?
| | Connective Tissue | 1 | 2000 | 37 | 0.180 |
Why?
| | Peritoneal Neoplasms | 1 | 2001 | 86 | 0.170 |
Why?
| | Skull Fractures | 1 | 2000 | 33 | 0.170 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2000 | 21 | 0.170 |
Why?
| | Vitelline Duct | 1 | 2000 | 1 | 0.170 |
Why?
| | Intracranial Hemorrhages | 1 | 2000 | 78 | 0.170 |
Why?
| | Radiotherapy | 2 | 2019 | 185 | 0.170 |
Why?
| | Prognosis | 5 | 2014 | 3773 | 0.160 |
Why?
| | Intestinal Obstruction | 1 | 2000 | 49 | 0.160 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1284 | 0.150 |
Why?
| | Bevacizumab | 1 | 2019 | 128 | 0.150 |
Why?
| | Intestine, Small | 1 | 2000 | 151 | 0.150 |
Why?
| | Corpus Callosum | 1 | 2019 | 65 | 0.150 |
Why?
| | Parents | 1 | 2007 | 1319 | 0.150 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2019 | 51 | 0.150 |
Why?
| | Esophagoscopy | 2 | 2020 | 198 | 0.150 |
Why?
| | tau Proteins | 1 | 2019 | 77 | 0.150 |
Why?
| | Disease-Free Survival | 2 | 2014 | 647 | 0.150 |
Why?
| | Radiopharmaceuticals | 2 | 2013 | 168 | 0.150 |
Why?
| | Fatty Liver | 2 | 2012 | 230 | 0.150 |
Why?
| | Fluorodeoxyglucose F18 | 2 | 2013 | 128 | 0.140 |
Why?
| | Angiogenesis Inhibitors | 1 | 2019 | 218 | 0.140 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2003 | 1560 | 0.140 |
Why?
| | Fatal Outcome | 4 | 2016 | 300 | 0.140 |
Why?
| | Magnetic Resonance Angiography | 1 | 2019 | 234 | 0.140 |
Why?
| | Smith-Magenis Syndrome | 1 | 2017 | 2 | 0.140 |
Why?
| | Central Nervous System Neoplasms | 1 | 2019 | 149 | 0.140 |
Why?
| | Moyamoya Disease | 1 | 2017 | 19 | 0.140 |
Why?
| | White Matter | 1 | 2019 | 135 | 0.140 |
Why?
| | Treatment Outcome | 8 | 2014 | 10241 | 0.130 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 6 | 0.130 |
Why?
| | Young Adult | 6 | 2015 | 12467 | 0.130 |
Why?
| | Hyperammonemia | 1 | 2016 | 16 | 0.130 |
Why?
| | Bronchopulmonary Sequestration | 1 | 1996 | 8 | 0.130 |
Why?
| | Multimodal Imaging | 2 | 2019 | 110 | 0.130 |
Why?
| | Leigh Disease | 2 | 2013 | 19 | 0.130 |
Why?
| | Stomach | 1 | 1996 | 109 | 0.130 |
Why?
| | Intracranial Thrombosis | 1 | 2016 | 16 | 0.130 |
Why?
| | Brain Infarction | 1 | 2016 | 23 | 0.130 |
Why?
| | Cerebral Veins | 1 | 2016 | 15 | 0.130 |
Why?
| | Vascular Malformations | 1 | 2016 | 51 | 0.130 |
Why?
| | Contrast Media | 3 | 2019 | 394 | 0.120 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 16 | 0.120 |
Why?
| | Cavernous Sinus Thrombosis | 1 | 2015 | 9 | 0.120 |
Why?
| | Portal Vein | 1 | 2016 | 108 | 0.120 |
Why?
| | DNA Mutational Analysis | 2 | 2014 | 379 | 0.120 |
Why?
| | Adrenal Gland Neoplasms | 1 | 1996 | 83 | 0.120 |
Why?
| | Neurosurgical Procedures | 1 | 2017 | 168 | 0.120 |
Why?
| | Cerebral Infarction | 1 | 2015 | 42 | 0.120 |
Why?
| | Temporal Lobe | 1 | 2015 | 86 | 0.120 |
Why?
| | Abdominal Pain | 2 | 2011 | 143 | 0.120 |
Why?
| | Fibrin Fibrinogen Degradation Products | 2 | 2012 | 82 | 0.120 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.120 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.120 |
Why?
| | Carotid Stenosis | 1 | 2015 | 84 | 0.110 |
Why?
| | Spasm | 1 | 2013 | 20 | 0.110 |
Why?
| | Metal Metabolism, Inborn Errors | 1 | 2012 | 5 | 0.100 |
Why?
| | Alzheimer Disease | 1 | 2019 | 516 | 0.100 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 48 | 0.100 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 11 | 0.100 |
Why?
| | Pons | 1 | 2012 | 26 | 0.100 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2012 | 98 | 0.100 |
Why?
| | DNA, Mitochondrial | 1 | 2013 | 190 | 0.100 |
Why?
| | Athletic Injuries | 2 | 2016 | 510 | 0.090 |
Why?
| | Accidents | 1 | 2012 | 38 | 0.090 |
Why?
| | Craniotomy | 1 | 2012 | 68 | 0.090 |
Why?
| | Splenomegaly | 1 | 2011 | 16 | 0.090 |
Why?
| | Hemoglobin SC Disease | 1 | 2011 | 13 | 0.090 |
Why?
| | Necrosis | 3 | 2019 | 234 | 0.090 |
Why?
| | Decompression, Surgical | 1 | 2012 | 96 | 0.090 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 167 | 0.090 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.090 |
Why?
| | Anticoagulants | 1 | 2015 | 637 | 0.090 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 7 | 0.090 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 541 | 0.090 |
Why?
| | Liver Diseases | 2 | 2010 | 291 | 0.090 |
Why?
| | Scoliosis | 1 | 2013 | 199 | 0.080 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2010 | 71 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 262 | 0.080 |
Why?
| | Recurrence | 3 | 2022 | 1013 | 0.080 |
Why?
| | Mitochondrial Diseases | 1 | 2010 | 90 | 0.080 |
Why?
| | Incidental Findings | 1 | 2010 | 80 | 0.080 |
Why?
| | Thrombophilia | 1 | 2009 | 81 | 0.080 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 54 | 0.080 |
Why?
| | Optic Neuritis | 1 | 2009 | 40 | 0.080 |
Why?
| | Facial Bones | 1 | 2009 | 28 | 0.080 |
Why?
| | Facial Injuries | 1 | 2009 | 18 | 0.080 |
Why?
| | Liver | 2 | 2016 | 1839 | 0.080 |
Why?
| | Autopsy | 2 | 2016 | 92 | 0.080 |
Why?
| | Cerebellar Neoplasms | 1 | 2010 | 150 | 0.080 |
Why?
| | Aging | 1 | 2019 | 1774 | 0.080 |
Why?
| | Chromosomes, Human, Y | 1 | 2008 | 20 | 0.070 |
Why?
| | Diabetes, Gestational | 1 | 2012 | 308 | 0.070 |
Why?
| | Medulloblastoma | 1 | 2010 | 191 | 0.070 |
Why?
| | Prenatal Diagnosis | 1 | 2010 | 196 | 0.070 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2009 | 95 | 0.070 |
Why?
| | Chromosomes, Human, X | 1 | 2008 | 69 | 0.070 |
Why?
| | Biopsy | 2 | 2010 | 1089 | 0.070 |
Why?
| | Sex Chromosome Aberrations | 1 | 2008 | 62 | 0.070 |
Why?
| | Lung Diseases | 1 | 2014 | 743 | 0.070 |
Why?
| | Meningomyelocele | 1 | 2008 | 56 | 0.070 |
Why?
| | Craniopharyngioma | 1 | 2009 | 74 | 0.070 |
Why?
| | Aneuploidy | 1 | 2008 | 92 | 0.070 |
Why?
| | Ultrasonography, Doppler | 1 | 2008 | 118 | 0.070 |
Why?
| | Obesity | 2 | 2012 | 2885 | 0.070 |
Why?
| | Glioblastoma | 1 | 2010 | 322 | 0.070 |
Why?
| | Brain Injuries | 1 | 2012 | 466 | 0.070 |
Why?
| | Abnormalities, Multiple | 1 | 2008 | 175 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 355 | 0.070 |
Why?
| | Adult | 8 | 2019 | 35634 | 0.070 |
Why?
| | Brain Ischemia | 1 | 2009 | 321 | 0.060 |
Why?
| | Vascular Diseases | 1 | 2009 | 240 | 0.060 |
Why?
| | Carotid Artery Thrombosis | 1 | 2005 | 7 | 0.060 |
Why?
| | Mucormycosis | 1 | 2005 | 22 | 0.060 |
Why?
| | Osteoporosis | 1 | 2008 | 231 | 0.060 |
Why?
| | Developmental Disabilities | 1 | 2008 | 254 | 0.060 |
Why?
| | Bone Density | 1 | 2008 | 463 | 0.060 |
Why?
| | Metabolic Syndrome | 1 | 2008 | 340 | 0.060 |
Why?
| | Meninges | 1 | 2024 | 42 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2016 | 4896 | 0.050 |
Why?
| | Feasibility Studies | 2 | 2019 | 870 | 0.050 |
Why?
| | Meningeal Neoplasms | 1 | 2024 | 94 | 0.050 |
Why?
| | Meningitis | 1 | 2024 | 79 | 0.050 |
Why?
| | Carboplatin | 1 | 2003 | 139 | 0.050 |
Why?
| | Vincristine | 1 | 2003 | 108 | 0.050 |
Why?
| | Ascorbic Acid | 1 | 2024 | 120 | 0.050 |
Why?
| | Sinusitis | 1 | 2005 | 211 | 0.050 |
Why?
| | Risk Factors | 5 | 2012 | 9801 | 0.050 |
Why?
| | Hernia, Hiatal | 1 | 2003 | 32 | 0.050 |
Why?
| | Pilot Projects | 2 | 2019 | 1597 | 0.050 |
Why?
| | Pancreatic Neoplasms | 1 | 2010 | 879 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 24 | 0.050 |
Why?
| | Hemangioendothelioma | 1 | 2002 | 15 | 0.050 |
Why?
| | Liver Transplantation | 1 | 2009 | 833 | 0.050 |
Why?
| | Colorado | 4 | 2015 | 4410 | 0.050 |
Why?
| | Ultrasonography, Prenatal | 2 | 2010 | 276 | 0.050 |
Why?
| | Spinal Cord Neoplasms | 1 | 2001 | 37 | 0.050 |
Why?
| | Neurofibromatosis 1 | 1 | 2001 | 50 | 0.040 |
Why?
| | Vitamin K Deficiency | 1 | 2000 | 8 | 0.040 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2000 | 33 | 0.040 |
Why?
| | Cross-Sectional Studies | 4 | 2019 | 5085 | 0.040 |
Why?
| | Dilatation | 1 | 2020 | 61 | 0.040 |
Why?
| | Herpes Simplex | 1 | 2000 | 92 | 0.040 |
Why?
| | Enema | 1 | 2000 | 43 | 0.040 |
Why?
| | Mental Disorders | 1 | 2008 | 1035 | 0.040 |
Why?
| | Diseases in Twins | 1 | 2000 | 175 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 64 | 0.040 |
Why?
| | Neck | 1 | 2019 | 95 | 0.040 |
Why?
| | Ependymoma | 1 | 2001 | 161 | 0.040 |
Why?
| | Carbolines | 1 | 2019 | 30 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2748 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 2019 | 89 | 0.040 |
Why?
| | Thiazoles | 1 | 2019 | 118 | 0.040 |
Why?
| | Biomarkers | 1 | 2009 | 3971 | 0.040 |
Why?
| | Atrophy | 1 | 2019 | 170 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 1951 | 0.040 |
Why?
| | Aniline Compounds | 1 | 2019 | 97 | 0.040 |
Why?
| | Cohort Studies | 3 | 2016 | 5444 | 0.040 |
Why?
| | Pregnancy | 5 | 2012 | 6423 | 0.040 |
Why?
| | Organ Size | 1 | 2019 | 456 | 0.040 |
Why?
| | Gastroepiploic Artery | 1 | 2017 | 4 | 0.030 |
Why?
| | Cerebral Revascularization | 1 | 2017 | 19 | 0.030 |
Why?
| | Dexamethasone | 1 | 2019 | 352 | 0.030 |
Why?
| | Phenotype | 2 | 2019 | 3062 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 2017 | 108 | 0.030 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 38 | 0.030 |
Why?
| | Acidosis, Lactic | 1 | 2016 | 46 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 530 | 0.030 |
Why?
| | Congenital Abnormalities | 1 | 1996 | 76 | 0.030 |
Why?
| | Florida | 1 | 2015 | 93 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2017 | 148 | 0.030 |
Why?
| | Endpoint Determination | 1 | 2015 | 76 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2019 | 582 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2015 | 271 | 0.030 |
Why?
| | Observer Variation | 1 | 2015 | 314 | 0.030 |
Why?
| | Combined Modality Therapy | 2 | 2009 | 1201 | 0.030 |
Why?
| | Hemorrhage | 2 | 2015 | 680 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 318 | 0.030 |
Why?
| | Molybdoferredoxin | 1 | 2012 | 12 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2015 | 326 | 0.020 |
Why?
| | Pedigree | 1 | 2013 | 483 | 0.020 |
Why?
| | Erythroblastosis, Fetal | 1 | 1972 | 3 | 0.020 |
Why?
| | Persistent Vegetative State | 1 | 2012 | 3 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 6550 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2724 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3384 | 0.020 |
Why?
| | Glasgow Coma Scale | 1 | 2012 | 165 | 0.020 |
Why?
| | Disabled Children | 1 | 2012 | 68 | 0.020 |
Why?
| | Splenectomy | 1 | 2011 | 58 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 31177 | 0.020 |
Why?
| | Karyotyping | 1 | 2010 | 99 | 0.020 |
Why?
| | Accidents, Traffic | 1 | 2012 | 184 | 0.020 |
Why?
| | Anemia | 1 | 1972 | 162 | 0.020 |
Why?
| | Aged | 2 | 2019 | 22107 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2010 | 187 | 0.020 |
Why?
| | Factor VIII | 1 | 2009 | 87 | 0.020 |
Why?
| | Rare Diseases | 1 | 2010 | 96 | 0.020 |
Why?
| | Optic Nerve | 1 | 2009 | 64 | 0.020 |
Why?
| | Research Design | 1 | 2015 | 1045 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2005 | 3630 | 0.020 |
Why?
| | Body Composition | 1 | 2012 | 649 | 0.020 |
Why?
| | Fractures, Spontaneous | 1 | 2008 | 11 | 0.020 |
Why?
| | Wheelchairs | 1 | 2008 | 16 | 0.020 |
Why?
| | Fetal Diseases | 1 | 2010 | 164 | 0.020 |
Why?
| | Calcium, Dietary | 1 | 2008 | 56 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 756 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2008 | 114 | 0.020 |
Why?
| | Cesarean Section | 1 | 2010 | 183 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2010 | 319 | 0.020 |
Why?
| | Mobility Limitation | 1 | 2008 | 61 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 494 | 0.020 |
Why?
| | Gestational Age | 2 | 2010 | 876 | 0.020 |
Why?
| | Adiposity | 1 | 2012 | 504 | 0.020 |
Why?
| | Recovery of Function | 1 | 2012 | 645 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 247 | 0.020 |
Why?
| | Pancreatectomy | 1 | 2010 | 242 | 0.020 |
Why?
| | Prenatal Care | 1 | 2010 | 277 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 338 | 0.020 |
Why?
| | Bleomycin | 1 | 2009 | 243 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2009 | 401 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2008 | 205 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7066 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2142 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 2057 | 0.020 |
Why?
| | Mucor | 1 | 2005 | 7 | 0.020 |
Why?
| | Telencephalon | 1 | 2005 | 15 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1872 | 0.020 |
Why?
| | Cavernous Sinus | 1 | 2005 | 17 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2833 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2010 | 1690 | 0.020 |
Why?
| | Triglycerides | 1 | 2008 | 528 | 0.020 |
Why?
| | Orbit | 1 | 2005 | 58 | 0.020 |
Why?
| | Paranasal Sinuses | 1 | 2005 | 76 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2010 | 1327 | 0.010 |
Why?
| | Prospective Studies | 2 | 2009 | 7158 | 0.010 |
Why?
| | Incidence | 1 | 2009 | 2646 | 0.010 |
Why?
| | Cleft Lip | 1 | 2003 | 43 | 0.010 |
Why?
| | United States | 1 | 2019 | 13913 | 0.010 |
Why?
| | Cleft Palate | 1 | 2003 | 57 | 0.010 |
Why?
| | Estrogen Receptor Modulators | 1 | 2001 | 17 | 0.010 |
Why?
| | Laminectomy | 1 | 2001 | 29 | 0.010 |
Why?
| | Etoposide | 1 | 2001 | 148 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1736 | 0.010 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2001 | 208 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 3269 | 0.010 |
Why?
| | Tamoxifen | 1 | 2001 | 197 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2001 | 377 | 0.010 |
Why?
| | Low Back Pain | 1 | 2001 | 105 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2274 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 176 | 0.010 |
Why?
| | Blood Glucose | 1 | 2008 | 2103 | 0.010 |
Why?
| | Appendicitis | 1 | 1999 | 125 | 0.010 |
Why?
| | Acute Disease | 1 | 1999 | 980 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2001 | 957 | 0.010 |
Why?
| | Parathyroid Glands | 1 | 1975 | 9 | 0.010 |
Why?
| | Infant, Newborn, Diseases | 1 | 1975 | 111 | 0.010 |
Why?
| | Pregnancy in Diabetics | 1 | 1975 | 118 | 0.010 |
Why?
| | Kidney Cortex Necrosis | 1 | 1972 | 1 | 0.010 |
Why?
| | Splenic Rupture | 1 | 1972 | 4 | 0.010 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 1972 | 15 | 0.010 |
Why?
| | Hemoperitoneum | 1 | 1972 | 12 | 0.010 |
Why?
| | Brain Edema | 1 | 1972 | 61 | 0.010 |
Why?
| | Pulmonary Edema | 1 | 1972 | 106 | 0.010 |
Why?
| | Pancreatic Diseases | 1 | 1972 | 71 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1972 | 105 | 0.010 |
Why?
| | Spleen | 1 | 1972 | 508 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 1972 | 403 | 0.000 |
Why?
| | Emergency Service, Hospital | 1 | 1999 | 1920 | 0.000 |
Why?
| | Hypocalcemia | 1 | 1975 | 27 | 0.000 |
Why?
| | Umbilical Cord | 1 | 1975 | 83 | 0.000 |
Why?
| | Blood | 1 | 1975 | 105 | 0.000 |
Why?
| | Magnesium | 1 | 1975 | 155 | 0.000 |
Why?
| | Phosphorus | 1 | 1975 | 92 | 0.000 |
Why?
| | Parathyroid Hormone | 1 | 1975 | 106 | 0.000 |
Why?
| | Phosphates | 1 | 1975 | 181 | 0.000 |
Why?
| | Calcium | 1 | 1975 | 1212 | 0.000 |
Why?
|
|
Fenton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|